StonvexLoading…
StonvexCore line items from UL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | €50.50B | €52.48B | €51.68B | €60.07B |
Operating Income | €9.04B | €8.83B | €9.00B | €10.76B |
Net Income | €10.01B | €6.37B | €7.14B | €8.27B |
EPS (Diluted) | €4.32 | €2.58 | €2.89 | €2.99 |
Total Assets | €70.47B | €79.75B | €75.27B | €77.82B |
Total Liabilities | €52.88B | €57.20B | €54.50B | €56.12B |
Cash & Equivalents | €3.94B | €6.14B | €4.16B | €4.33B |
Free Cash Flow OCF − CapEx | €6.93B | €8.14B | €8.23B | €5.83B |
Shares Outstanding | Not available | Not available | Not available | Not available |